Detalhe da pesquisa
1.
Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.
Ann Intern Med
; 177(2): 189-195, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38190712
2.
Immune Responses to Varicella-Zoster Virus Vaccines.
Curr Top Microbiol Immunol
; 438: 223-246, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-35102438
3.
Herpes zoster (HZ) vaccine coverage and confidence in Italy: a Nationwide cross-sectional study, the OBVIOUS project.
BMC Infect Dis
; 24(1): 438, 2024 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38658871
4.
BioNTech COVID-19 (BNT162b2) Vaccination and Varicella Zoster Reactivation: A Comprehensive Cross-sectional Study.
Acta Derm Venereol
; 104: adv18389, 2024 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38348725
5.
Cost of illness of the vaccine-preventable diseases influenza, herpes zoster and pneumococcal disease in France.
Eur J Public Health
; 34(1): 170-175, 2024 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38061039
6.
Factors associated with shingles and pneumococcal vaccination among older Canadians.
Health Rep
; 35(1): 14-24, 2024 Jan 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38232409
7.
Herpes zoster: treatment, management, and prevention with the recombinant DNA vaccine.
Gen Dent
; 72(1): 54-57, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38117642
8.
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy.
Medicina (Kaunas)
; 60(1)2024 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38256354
9.
Predictors of 5-Year Persistence of Antibody Responses to Zoster Vaccines.
J Infect Dis
; 228(10): 1367-1374, 2023 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37141390
10.
Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database.
J Infect Dis
; 228(10): 1326-1335, 2023 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37549237
11.
No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Aged 50 Years and Older: A Randomized Trial.
Clin Infect Dis
; 77(9): 1238-1246, 2023 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37335963
12.
Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine.
Clin Infect Dis
; 76(3): e1335-e1340, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35796546
13.
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data.
Am J Epidemiol
; 192(2): 205-216, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36193854
14.
Sequential Data-Mining for Adverse Events After Recombinant Herpes Zoster Vaccination Using the Tree-Based Scan Statistic.
Am J Epidemiol
; 192(2): 276-282, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36227263
15.
Disseminated vaccine-induced varicella infection in a kidney transplant recipient.
Am J Transplant
; 23(11): 1806-1810, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37286085
16.
The value of herpes zoster prevention in people aging with HIV: A narrative review.
HIV Med
; 24(12): 1190-1197, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37772682
17.
Assessment of attenuation of varicella-zoster virus vaccines based on genomic comparison.
J Med Virol
; 95(3): e28590, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36807919
18.
Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
Respir Res
; 24(1): 35, 2023 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36709298
19.
Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine.
J Gen Intern Med
; 38(4): 986-993, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35794307
20.
Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years.
Value Health
; 26(2): 204-215, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36243666